abstract |
The present invention relates to compounds, tautomers and pharmaceutically acceptable salts of the disclosed compounds, wherein said compounds have the structure of formula I , and the variable R1 is as defined in the specification. The corresponding pharmaceutical composition, treatment method, synthesis method and intermediate are also disclosed. |